← Evidence map

ArticleJournal of cancer research and clinical oncology2014

Polymorphisms in TS, MTHFR and ERCC1 genes as predictive markers in first-line platinum and pemetrexed therapy in NSCLC patients.

Paweł Krawczyk et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

18 papers cite it

2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
this paperpooled ittrialcites it

The trial

Full record →Abstract, authors, funding and every citing paper · PMID 25028118